Clinical Trial Update: ATG-008 Combined With Toripalimab in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates for ATG-008 in combination with toripalimab in advanced solid tumors are in Phase 1 and Phase 2, with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ATG 008 (dual mTORC1/2 inhibitor)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sichuan University | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN